methylenedioxymethamphetamine, and phency-
clidine abuse; and 
‘‘(E) engage in other activities that the 
Secretary has determined are relevant to the 
purpose of the grants under subsection (a). 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2014 
through 2018. 
‘‘SEC. 514D. HEROIN, COCAINE, METHAMPHETAMINE, EC-
STASY, AND PCP ABUSE TREATMENT VOUCH-
ERS FOR UNDERSERVED POPULATIONS. 
‘‘(a) IN GENERAL.—The Secretary may make grants 
to State, local, and tribal governments and nonprofit enti-
ties to provide vouchers to individuals in underserved pop-
ulations for authorized services related to the treatment 
of such individuals for heroin, cocaine, methamphetamine, 
3,4-methylenedioxymethamphetamine (ecstasy), and phen-
cyclidine (PCP) abuse. 
‘‘(b) REQUIREMENTS.— 
‘‘(1) APPLICATION.—To seek a grant under 
subsection (a), a State, local, or tribal government 
or a nonprofit entity shall submit an application to 
the Secretary at such time, in such manner, and 
containing such information and assurances as the 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
Secretary may require, including a description of the 
method that such State, government, or entity will 
use— 
‘‘(A) to identify individuals who would ben-
efit from treatment for heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine abuse; 
‘‘(B) to identify if such individuals are in 
underserved populations; and 
‘‘(C) to provide vouchers to such individ-
uals in such populations. 
‘‘(2) PRESERVATION OF CHOICE.—A recipient 
of a grant under this section may not restrict the 
ability of an individual receiving a voucher under 
this section to use the voucher to pay for authorized 
services furnished by any provider of authorized 
services, so long as the provider of such services 
meets all applicable State licensure or certification 
requirements regarding the provision of such serv-
ices. 
‘‘(3) DURATION OF AWARD.—With respect to a 
grant under this section, the period during which 
payments under such grant are made to the grant 
recipient may not exceed five years. 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
‘‘(4) MATCHING
FUNDS.—The Secretary may 
require that recipients of grants under this section 
provide non-Federal matching funds, as determined 
appropriate by the Secretary, to ensure the commit-
ment of the grant recipients to the provision of 
vouchers for treatment to individuals who use her-
oin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine. Such non-Fed-
eral matching funds may be provided directly or 
through donations from public or private entities 
and may be in cash or in-kind, fairly evaluated, in-
cluding property, equipment, or services. 
‘‘(5) MAINTENANCE
OF
EFFORT.—The Sec-
retary may require that grant recipients under this 
section agree to maintain expenditures of non-Fed-
eral amounts for authorized services related to the 
treatment of heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine, and phencyclidine 
abuse at a level that is not less than the level of 
such expenditures maintained by the recipient for 
the fiscal year preceding the fiscal year for which 
the entity receives such a grant. 
‘‘(c) REPORT.— 
‘‘(1) IN GENERAL.—Not later than December 1, 
2014, and annually thereafter, the Secretary shall 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
submit a report to the Congress on the grants under 
subsection (a). 
‘‘(2) CONTENTS OF REPORT.—The report under 
paragraph (1) shall contain an evaluation of the ef-
fectiveness of the grants made under subsection (a) 
in improving access to heroin, cocaine, methamphet-
amine, 3,4-methylenedioxymethamphetamine, and 
phencyclidine treatment for underserved populations. 
‘‘(d) DEFINITIONS.—For purposes of this section: 
‘‘(1) AUTHORIZED SERVICES.—The term ‘au-
thorized services’ means— 
‘‘(A) treatment for heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine abuse, including indi-
vidual, group, and family counseling regarding 
such abuse; 
‘‘(B) follow-up services to prevent an indi-
vidual from relapsing into such abuse; 
‘‘(C) wrap-around services, as such term is 
defined in section 514E(e)(4); and 
‘‘(D) any additional services specified by 
the Secretary. 
‘‘(2) UNDERSERVED
POPULATION.—The term 
‘underserved population’ means a population of indi-
viduals who cannot access appropriate substance 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
abuse treatment (including comprehensive substance 
abuse treatment) due to financial, geographical, lan-
guage, socioeconomic, or cultural barriers. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2014 
through 2018. 
‘‘SEC. 514E. COMPREHENSIVE WRAP-AROUND HEROIN, CO-
CAINE, METHAMPHETAMINE, 3,4-METHYLENE-
DIOXYMETHAMPHETAMINE (ECSTASY), AND 
PHENCYCLIDINE (PCP) TREATMENT SERV-
ICES. 
‘‘(a) IN GENERAL.—The Secretary may make grants 
to public, private, and nonprofit entities, Indian tribes, 
and tribal organizations to establish programs to provide 
for and coordinate the provision of wrap-around services 
to heroin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine-affected individuals. 
‘‘(b) MINIMUM QUALIFICATIONS FOR RECEIPT OF 
AWARD.—To seek a grant under subsection (a), a public, 
private, or nonprofit entity, an Indian tribe, or a tribal 
organization shall submit an application to the Secretary 
at such time, in such manner, and containing such infor-
mation and assurances as the Secretary may require, in-
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
cluding assurances to the satisfaction of the Secretary 
that— 
‘‘(1) the applicant has the capacity to carry out 
a program described in subsection (a); 
‘‘(2) the applicant has entered into agreements 
with entities in the community involved, through 
which the applicant will provide wrap-around serv-
ices; and 
‘‘(3) the applicant, or any entity through which 
the applicant will provide such services, meets all ap-
plicable State licensure or certification requirements 
regarding the provision of such services. 
‘‘(c) PRIORITY FOR GRANT DISTRIBUTION.—In mak-
ing grants under this section, the Secretary shall give pri-
ority to applications for programs that serve communities 
with a high or increasing rate of heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphetamine, or 
phencyclidine abuse or addiction, as specified by the Sec-
retary. 
‘‘(d) REPORTS.—For each year that a public, private, 
or nonprofit entity, Indian tribe, or tribal organization re-
ceives a grant under subsection (a) for a program, such 
entity, tribe, or organization shall submit to the Secretary 
a report on the results and effectiveness of the program. 
‘‘(e) DEFINITIONS.—For purposes of this section: 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
‘‘(1) HEROIN, COCAINE, METHAMPHETAMINE, 
3,4-METHYLENEDIOXYMETHAMPHETAMINE, 
OR 
PHENCYCLIDINE-AFFECTED INDIVIDUAL.—The term 
‘heroin, cocaine, methamphetamine, 3,4-methylene-
dioxymethamphetamine, or phencyclidine-affected in-
dividual’ means an individual who— 
‘‘(A)(i) resided in a residential inpatient 
treatment facility for the treatment of heroin, 
cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine abuse or 
addiction; or 
‘‘(ii) received treatment for heroin, cocaine, 
methamphetamine, 3,4-methylenedioxymetham-
phetamine, or phencyclidine abuse or addiction 
from an intensive outpatient treatment facility; 
and 
‘‘(B) after successful completion of such 
treatment reenters the community. 
‘‘(2) INTENSIVE OUTPATIENT TREATMENT FA-
CILITY.—The term ‘intensive outpatient treatment 
facility’ means a facility that provides treatment for 
substance abuse and that, with respect to an indi-
vidual receiving such treatment— 
‘‘(A) provides a minimum of seven hours of 
treatment for substance abuse during a week; 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
‘‘(B) provides regularly scheduled treat-
ment sessions within a structured program; and 
‘‘(C) ensures that the treatment sessions 
are led by health professionals or clinicians. 
‘‘(3) RESIDENTIAL INPATIENT TREATMENT FA-
CILITY.—The term ‘residential inpatient treatment 
facility’ means a facility that provides treatment for 
substance abuse in which health professionals and 
clinicians provide a planned regimen of 24-hour pro-
fessionally directed evaluation, care, and treatment 
for such substance abuse in an inpatient setting, in-
cluding 24-hour observation and monitoring. 
‘‘(4) 
WRAP-AROUND
SERVICES.—The 
term 
‘wrap-around services’ means, with respect to a her-
oin, cocaine, methamphetamine, 3,4-methylenedioxy-
methamphetamine, or phencyclidine-affected indi-
vidual, the following services: 
‘‘(A) Medical services. 
‘‘(B) Dental services. 
‘‘(C) Mental health services. 
‘‘(D) Child care services. 
‘‘(E) Job training services. 
‘‘(F) Housing assistance. 
‘‘(G) Training in parenting. 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
‘‘(H) Prevention services for family mem-
bers, with respect to heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, and phencyclidine abuse or addiction. 
‘‘(I) Transportation assistance services for 
purposes of participation in the services listed 
in subparagraphs (A) through (H). 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2014 
through 2018.’’. 
SEC. 4. EXTENSION AND EXPANSION OF RESIDENTIAL 
TREATMENT PROGRAM FOR PREGNANT AND 
POSTPARTUM WOMEN TO INCLUDE CARE-
GIVER PARENTS. 
Section 508 of the Public Health Service Act (42 
U.S.C. 290bb–1) is amended— 
(1) in the heading, by striking ‘‘PREGNANT AND 
POSTPARTUM
WOMEN’’ and inserting ‘‘CAREGIVER 
PARENTS, INCLUDING PREGNANT WOMEN’’; 
(2) in subsection (a)— 
(A) in the matter preceding paragraph 
(1)— 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(i) by inserting ‘‘, Indian tribes, and 
tribal organizations’’ after ‘‘nonprofit pri-
vate entities’’; and 
(ii) 
by 
striking 
‘‘pregnant 
and 
postpartum women treatment for sub-
stance abuse’’ and inserting ‘‘caregiver 
parents, including pregnant women, treat-
ment for substance abuse (including treat-
ment for addiction to heroin, cocaine, 
methamphetamine, 
3,4-methylenedioxy-
methamphetamine (ecstasy), or phencycli-
dine (PCP))’’; 
(B) in each of paragraphs (1), (2), and 
(3), by striking ‘‘the women’’ and inserting 
‘‘such parents’’ each place it appears; and 
(C) in paragraph (3), by inserting ‘‘supple-
mental’’ before ‘‘services’’; 
(3) in subsection (b)— 
(A) in paragraph (1), by inserting ‘‘, In-
dian tribes, or tribal organizations’’ after ‘‘non-
profit private entities’’; and 
(B) in paragraph (2)— 
(i) by striking ‘‘the services’’ and in-
serting ‘‘such services’’; and 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(ii) by striking ‘‘woman’’ and insert-
ing ‘‘caregiver parent’’; 
(4) in subsection (c)— 
(A) in paragraph (1), by striking ‘‘eligible 
woman’’ and inserting ‘‘eligible caregiver par-
ent’’; and 
(B) by striking ‘‘the women’’ and ‘‘the 
woman’’ each place either term appears and in-
serting ‘‘such parent’’; 
(5) in subsection (d)— 
(A) in the matter proceeding paragraph 
(1), by striking ‘‘woman’’ and inserting ‘‘care-
giver parent’’; 
(B) in paragraphs (3) and (4), by striking 
‘‘the woman’’ and inserting ‘‘such parent’’ each 
place it appears; 
(C) in paragraph (9)— 
(i) by striking ‘‘the women’’ and in-
serting ‘‘such parent’’ each place it ap-
pears; 
(ii) by striking ‘‘units’’ and inserting 
‘‘unit’’; and 
(iii) by striking ‘‘of parents’’ and in-
serting ‘‘of the parents of such parent’’; 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(D) in paragraph (10), by inserting ‘‘, In-
dian tribes, or tribal organizations’’ after ‘‘enti-
ties’’; and 
(E) in paragraph (11)— 
(i) by striking ‘‘the women’’ and in-
serting ‘‘such parent’’; and 
(ii) by striking ‘‘their children’’ and 
inserting ‘‘the children of such parent’’; 
(6) in subsection (f)(1), in the matter pro-
ceeding subparagraph (A) by inserting ‘‘, Indian 
tribes, or tribal organizations’’ after ‘‘public or pri-
vate entities’’; 
(7) in subsection (g)— 
(A) by striking ‘‘identify women’’ and in-
serting ‘‘identify caregiver parents’’; and 
(B) by striking ‘‘the women’’ and inserting 
‘‘such parents’’; 
(8) in subsection (h)(1), by striking ‘‘pregnant 
and postpartum women’’ and inserting ‘‘caregiver 
parents’’; 
(9) in subsection (j)— 
(A) in the matter proceeding paragraph 
(1)— 
(i) by striking ‘‘to on behalf’’ and in-
serting ‘‘to or on behalf’’; and 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(ii) by striking ‘‘woman’’ and insert-
ing ‘‘caregiver parent’’; 
(B) in paragraph (2), by striking ‘‘the 
woman’’ and inserting ‘‘such parent’’; and 
(C) in paragraph (3), by striking ‘‘woman’’ 
and inserting ‘‘parent’’; 
(10) in subsection (k)(2), by striking ‘‘women’’ 
and inserting ‘‘caregiver parents’’— 
(11) in subsection (l), by striking ‘‘such agree-
ments’’ and inserting ‘‘the funding agreements 
under this section’’; 
(12) by amending subsection (m) to read as fol-
lows: 
‘‘(m) USE
OF FUNDS; PRIORITY
FOR CERTAIN 
AREAS SERVED.— 
‘‘(1) USE OF FUNDS.—A funding agreement for 
an award under subsection (a) for an applicant is 
that funds awarded under subsection (a) to such ap-
plicant shall be used for programs according to the 
following order of priority: 
‘‘(A) For a program that provides services 
to caregiver parents who are pregnant and 
postpartum women. 
‘‘(B) For a program that provides services 
to caregiver parents who are single parents and 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
the sole caregivers with respect to their chil-
dren. 
‘‘(C) For a program that provides services 
to any caregiver parents. 
‘‘(2) PRIORITY FOR CERTAIN AREAS SERVED.— 
In making awards under subsection (a), the Director 
shall give priority to any entity, tribe, or organiza-
tion that agrees to use the award for a program 
serving an area that— 
‘‘(A) is an area determined by the Director 
to have a shortage of family-based substance 
abuse treatment options; or 
‘‘(B) is determined by the Director to have 
high rates of addiction to heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphet-
amine, or phencyclidine.’’; 
(13) in subsection (p)— 
(A) by striking ‘‘October 1, 1994’’ and in-
serting ‘‘January 1, 2014’’; 
(B) by striking ‘‘Committee on Labor and 
Human Resources’’ and inserting ‘‘Committee 
on Health, Education, Labor, and Pensions’’; 
and 
(C) by striking the third sentence; 
(14) in subsection (q)— 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(A) by redesignating paragraphs (2), (3), 
(4), and (5) as paragraphs (3), (4), (5), and 
(6), respectively; 
(B) by inserting after paragraph (1) the 
following new paragraph: 
‘‘(2) The term ‘caregiver parent’ means, with 
respect to a child, a parent or legal guardian with 
whom the child resides, and includes a pregnant 
woman.’’; and 
(C) by amending paragraph (3), as redes-
ignated by subparagraph (A) of this paragraph, 
to read as follows: 
‘‘(3) The term ‘eligible caregiver parent’ means 
a caregiver parent who has been admitted to a pro-
gram operated pursuant to subsection (a).’’; and 
(15) in subsection (r), by striking ‘‘to fiscal 
years 2001 through 2003’’ and inserting ‘‘for fiscal 
years 2014 through 2018’’. 
SEC. 
5. 
EFFECTIVENESS 
OF 
STIMULANT 
TREATMENT 
METHODS. 
(a) RESEARCH.—The Director of the National Insti-
tute on Drug Abuse shall conduct research, directly or 
through contract with another entity, on the effectiveness 
of the use of agonist and antagonist drugs to reduce the 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
problems associated with stimulant abuse, including co-
caine and methamphetamine abuse. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2014 
through 2018. 
SEC. 6. IOM STUDY ON DRUG TREATMENTS FOR STIMU-
LANT ABUSE. 
(a) REPORT.—The Secretary of Health and Human 
Services shall seek to enter into a contract with the Insti-
tute of Medicine of the National Academies to complete 
a literature review and submit a report to Congress on 
the effectiveness of agonist and antagonist drugs for the 
treatment of stimulant abuse, including cocaine and meth-
amphetamine abuse. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section for fiscal years 2014 
through 2018. 
SEC. 7. GAO EVALUATION OF THE IMPACT OF THIS LEGIS-
LATION. 
(a) STUDY ON THE LEVEL OF FUNDING FOR TREAT-
MENT.—The Comptroller General of the United States 
shall conduct a study on— 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(1) the impact of the programs authorized by 
this Act (including the amendments made by this 
Act) on the effectiveness and availability of treat-
ment for heroin, cocaine, methamphetamine, 3,4- 
methylenedioxymethamphetamine, and phencyclidine 
abuse; 
(2) whether the level of Federal funding avail-
able for the treatment of heroin, cocaine, meth-
amphetamine, 3,4-methylenedioxymethamphetamine, 
and phencyclidine abuse meets, exceeds, or is less 
than the amount necessary to provide adequate 
treatment for such abuse; and 
(3) the impact of effective treatment of heroin, 
cocaine, methamphetamine, 3,4-methylenedioxymeth-
amphetamine, and phencyclidine abuse on cost sav-
ings due to the reduced need for criminal justice and 
other services. 
(b) REPORTS.— 
(1) INTERIM REPORT.—Not later than the last 
day of the two-year period beginning on the date of 
enactment of this Act, the Comptroller General shall 
submit to Congress a report on the interim findings 
of the study under subsection (a). 
(2) FINAL REPORT.—Not later than 3 years 
after the date on which the report under paragraph 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS
(1) is submitted to Congress, the Comptroller Gen-
eral shall submit to Congress a report on the find-
ings of the study under subsection (a). 
SEC. 8. NO ADDITIONAL APPROPRIATIONS. 
This Act, and the amendments made by this Act, 
shall not be construed to increase the amount of appro-
priations that are authorized to be approved for any fiscal 
year. 
Æ 
VerDate Mar 15 2010 
23:32 May 30, 2013
Jkt 029200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6301
E:\BILLS\H2130.IH
H2130
pwalker on DSK7TPTVN1PROD with BILLS